58
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Safety and Pharmacokinetics of Lopinavir in HIV/HCV Coinfected Patients with Advanced Liver Disease

, , , , , , , & show all
Pages 235-243 | Published online: 06 Jan 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Leonardo Calza, Ilaria Danese, Vincenzo Colangeli, Roberto Manfredi, Eleonora Magistrelli, Gabriella Verucchi, Matteo Conti, Roberto Motta & Pierluigi Viale. (2015) Plasma concentrations of efavirenz, darunavir/ritonavir and raltegravir in HIV-HCV-coinfected patients without liver cirrhosis in comparison with HIV-monoinfected patients. Infectious Diseases 47:9, pages 625-636.
Read now

Articles from other publishers (12)

Mohamed Elnaggar, Ahmed Abomhya, Ismail Elkhattib, Nabila Dawoud & Rajkumar Doshi. (2022) COVID-19 and liver diseases, what we know so far. World Journal of Clinical Cases 10:13, pages 3969-3980.
Crossref
Man Fai Law, Rita Ho, Kimmy Wan Tung Law & Carmen Ka Man Cheung. (2021) Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases. World Journal of Hepatology 13:12, pages 1850-1874.
Crossref
Samy Zaky, Mohamed Alboraie, Mohamed El Badry, Mohamed A. Metwally, Ahmed Abdelaziz, Yasser Fouad, Sherief Abd-Elsalam, Abdelmajeed Mahmoud, Gamal Shiha, Amin Abdel Baki, Mohamed El Kassas & Gamal Esmat. (2021) Management of liver disease patients in different clinical situations during COVID-19 pandemic. Egyptian Liver Journal 11:1.
Crossref
Marina G. Mnatsakanyan, Aleksandr P. Pogromov, Aleksei S. Lishuta, Victor V. Fomin, Olga S. Volkova, Olga V. Tashchyan, Irina V. Kuprina & Yuliia F. Shumskaya. (2021) Liver and COVID-19: possible mechanisms of damage. Terapevticheskii arkhiv 93:4, pages 427-430.
Crossref
Saeed Hamid, Mario R. Alvares da Silva, Kelly W. Burak, Tao Chen, Joost P.H. Drenth, Gamal Esmat, Rui Gaspar, Douglas LaBrecque, Alice Lee, Guilherme Macedo, Brian McMahon, Qin Ning, Nancy Reau, Mark Sonderup, Dirk J. van Leeuwen, David Armstrong & Cihan Yurdaydin. (2021) WGO Guidance for the Care of Patients With COVID-19 and Liver Disease. Journal of Clinical Gastroenterology 55:1, pages 1-11.
Crossref
Yoshio Sumida, Satoshi Kimoto, Kazumasa Sakamoto, Tomohiko Ohashi, Yukiomi Nakade, Kiyoaki Itou, Hidenori Toyoda, Eiichi Tomita, Takashi Kumada & Masashi Yoneda. (2020) Relationship between COVID-19 and liver diseases: the role of hepatologists in clinical practice新型コロナウイルス感染症(COVID-19)と肝疾患:肝臓専門医の役割. Kanzo 61:10, pages 496-503.
Crossref
Luis Téllez & Rosa María Martín Mateos. (2020) Actualización en COVID-19 y enfermedad hepática. Gastroenterología y Hepatología 43:8, pages 472-480.
Crossref
Luis Téllez & Rosa María Martín Mateos. (2020) COVID-19 and liver disease: An update. Gastroenterología y Hepatología (English Edition) 43:8, pages 472-480.
Crossref
Ashwin Rammohan. (2020) Post-transplant immunosuppression and COVID-19: From a double whammy to a mixed blessing. World Journal of Transplantation 10:9, pages 267-276.
Crossref
Saleh A. Alqahtani, Abdulrahman A. Aljumah, Almoutaz Hashim, Thamer H. Alenazi, Mohammed AlJawad, Waleed K. Al Hamoudi & Mohammed Y. Alghamdi. (2020) Principles of Care for Patients with Liver Disease During the Coronavirus Disease 2019 (COVID-19) Pandemic: Position Statement of the Saudi Association for the Study of Liver Disease and Transplantation. Annals of Saudi Medicine 40:4, pages 273-280.
Crossref
Isabel Garrido, Rodrigo Liberal & Guilherme Macedo. (2020) Review article: COVID-19 and liver disease-what we know on 1st May 2020. Alimentary Pharmacology & Therapeutics 52:2, pages 267-275.
Crossref
Michael Schultheiß, Sharon Kling, Ulrike Lenker, Miriam von Bibra, Bernd Rosenkranz & Hartwig Klinker. (2018) Lopinavir serum concentrations of critically ill infants: a pharmacokinetic investigation in South Africa. Medical Microbiology and Immunology 207:5-6, pages 339-343.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.